Collaboration is the best way to advance biopharmaceutical research and there remains ample opportunity for scientists in the US and China to work together on developing new medicines and technologies to combat diseases. That was the message from the Chinese Biopharmaceutical Association-USA (CBA), which held its 19th annual conference at the University of Maryland on June 21. One of the largest Chinese American professional associations, this year's conference was designed to address the importance of innovation and worldwide collaboration to capture opportunities for advancing modern medicine and biopharmaceuticals.